Prescription Digital Therapeutics

The AJMC® Prescription Digital Therapeutics compendium is a resource for news and interviews about prescription digital therapeutics and related technologies.

Future-Self Avatar Improves Health Motivation, but Not Behavioral Changes

July 13th 2022, 6:15pm


To reduce bias based on the user’s current health status, a mobile health intervention used a future-self avatar to help individuals understand long-term effects of physical activity and nutrition on their body.

Educating Peers About PDTs

July 11th 2022, 2:26pm


Our experts conclude by interpreting ways to better educate both payers and providers on PDTs.

Value-Based Pilot Programs for PDTs

July 11th 2022, 2:23pm


Diana Brixner, RPh, PhD, comments on how incorporating value-based pilot programs would impact her decision-making with PDT coverage as a payer.

Increasing Access to PDTs For All Parties

July 6th 2022, 5:29pm


Drs Podesta and Brixner discuss possible ways to improve access to PDTs for every party involved—patient, payer, and provider.

Improving the Payer-Provider Relationship Influencing PDT Use

July 6th 2022, 5:12pm


Two medical experts relay their ideas on how to better improve the payer-provider relationship surrounding PDT use.

How Machine Learning, Digital Therapeutics Improve Personalized Care

July 5th 2022, 7:19pm


Panelists at the National Alliance of Healthcare Purchaser Coalitions 2022 Leadership Summit discussed the latest innovations in digital therapeutics and how they benefit patients on an individual and broad scale.

Dr Debra Patt Highlights the High Usage of Digital Health Solutions at Texas Oncology

July 3rd 2022, 7:36pm


Digital health care has been a key initiative at Texas Oncology, because it ensure patients can receive better care at their home, explained Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology.

Stakeholders Address How Digital Therapeutics Can Bridge Unmet Needs in Behavioral Health Care

June 27th 2022, 8:45pm


Two stakeholders involved in investment and development of behavioral care services discuss the potential of digital therapeutics as a cost-effective alternative to address unmet mental health needs during an AHIP 2022 session.

Prescription Digital Therapeutic for SUD Linked to Lower Costs, Health Care Use

June 27th 2022, 7:15pm


Patients with substance abuse disorder (SUD) saw a significant reduction in hospital encounters and per-patient costs after the initiation of a prescription digital therapeutic.

PDT Coverage Decisions

June 27th 2022, 5:10pm


Dr Brixner highlights the important factors a payer must look at when determining PDT coverage, and Dr Podesta comments from the provider perspective.